John Cebe
Cardiovascular Disease · Greenville, SCNPI 1972595536
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $789 and has fallen 78.0% since, to $173 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in SC, where the typical reported total is $3,855.
Across 107 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$361
- Amgen$214
- Gilead$154
- Biosense Webster, Inc.$121
- Edwards Lifesciences$111
- Sanofi-aventis U.S. LLC$94
- plus $569 from 14 others
Across 9 payments — averaging $16,691 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$139K
- Abbott$6K
- Merck$5K
What the payments were for
- Food & beverage$1,625100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 36 | $361 |
| Amgen | 14 | $214 |
| Gilead | 14 | $154 |
| Biosense Webster, Inc. | 1 | $121 |
| Edwards Lifesciences | 1 | $111 |
| Sanofi-aventis U.S. LLC | 5 | $94 |
| Amarin Pharma, Inc. | 5 | $93 |
| Boehringer Ingelheim | 5 | $89 |
| AstraZeneca | 6 | $81 |
| Novartis | 5 | $71 |
| Bayer | 3 | $60 |
| Pfizer | 3 | $45 |
| Merck | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $23 |
| Abbott | 1 | $22 |
| Cook Medical LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Medtronic | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,625 in reported general payments places this provider in the 30th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Other cardiovascular disease in Greenville
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
- Christopher SalmonGreenville$54K
- Arthur EberlyGreenville$34K
- Tara HolderGreenville$20K
- Dev VazGreenville$14K
- Jon BittrickGreenville$13K
- James MerriamGreenville$11K
- Harold BlanksGreenville$9K
- Arthur SiachosGreenville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.